Micro(glial)-managing executive function: white matter inflammation drives catatonia.

Area of Science:

• Neuroscience
• Neuroimmunology
• Molecular Psychiatry

Background:

• White matter abnormalities are common in neuropsychiatric disorders like schizophrenia.
• The role of these abnormalities as a cause or consequence remains unclear.
• Reduced 2"-3"-cyclic nucleotide 3"-phosphodiesterase (CNP) levels are linked to catatonia in humans and mice.

Purpose of the Study:

• To investigate the relationship between reduced CNP levels, white matter inflammation, and catatonia.
• To elucidate the cellular mechanisms underlying CNP deficiency-induced catatonia.

Main Methods:

• Analysis of CNP levels, catatonia, and white matter inflammation in human subjects.
• Utilizing Cnp-/- mouse models with and without microglial ablation.
• Assessing the impact of microglial activity on catatonic behavior in mice.

Main Results:

• Reduced CNP levels correlated with catatonia and white matter inflammation in human participants.
• Microglial ablation in Cnp-/- mice prevented and reduced catatonic signs.
• This suggests microglial-mediated inflammation is a direct cause of catatonia.

Conclusions:

• Low-grade neuroinflammation and catatonic behavior can result from subtle myelin abnormalities.
• Microglial activation is identified as a key cellular mechanism linking myelin deficits to catatonia.
• This research highlights a potential therapeutic pathway targeting neuroinflammation in schizophrenia-related catatonia.